The debate around 5G’s safety is getting in the way of science
It seems 5G is likely as safe as any other cell phone technology—but that shouldn't preclude more research. More
It seems 5G is likely as safe as any other cell phone technology—but that shouldn't preclude more research. More
The University of Virginia Medical Center is ranked as the "best" hospital in Virginia by U.S. News & World Report, but the hospital is among the worst when it comes to suing patients for unpaid medical bills. More
Recovering addicts who say Purdue Pharma got them hooked on opioids are turning their heads at the company’s bankruptcy deal. Dr. Vikas Saini, president of the Lown Institute and co-chairman of the Right Care Alliance, said measuring dollars against human lives isn’t fair. “Both Purdue and the Sacklers are really kind of dodging what the truth is here,” said Saini. “They deserve to face real justice and honestly I don’t think real justice is about the money.” More
Why aren't private insurers prosecuting people who commit fraud? Because it would hurt their bottom line, a ProPublica investigation finds. More
Two stories in the recent news demonstrate how hospitals and debt collection agencies will go to extreme lengths to get the money they believe they are owed. More
The New York Times More
Five people who all were either patients or consulted with a west Nashville doctor said he offered to cure them of their incurable disease. “There are lots and lots of diseases that can't be cured. So when your doctor says I can cure you. Or, it's a good thing you came to me, you should start having your antenna raised,” Brownlee said. More
How undisclosed conflicts of interest may have put millions of pregnant and postpartum women at risk... More
Recent developments in research on financial conflicts of interest in medicine are helping health care watchdogs hold health professionals and institutions accountable for their financial relationships with industry. Read on! More
The numerous currently available public hospital quality rating systems frequently offer conflicting results, which may mislead stakeholders relying on the ratings to identify top-performing hospitals. Given that there is no gold standard for how a rating system should be constructed or perform and no objective way to compare the rating systems, we evaluated the strengths and weaknesses of four major public hospital quality rating systems based on our experience as physician scientists with methodological expertise in health care quality measurement. More
The driving factor in health decisions should be what’s best for the patient, not the corporation. More
Hospitals say such screenings provide valuable education about treatment options for the common medical condition, in which part of the intestine protrudes through a weak spot in the abdominal wall. But no research has been done on hernia screenings, and some experts worry that these outreach efforts — some of which showcase da Vinci robotic surgery devices made by Intuitive Surgical based in Sunnyvale, Calif. — could lead people to get potentially harmful operations they don’t need. More
As the University of Kansas Hospital prepares to proudly unveil their new proton beam machine, they should also be preparing to answer some tough questions about the cost and effectiveness of this therapy. More
Can we trust drug companies to monitor and regulate the safety of their own products? More
Should patients be on the hook for ambulance rides for non-emergencies? It's not that simple, write Dr. Surafel Tsega and Dr. Harry Cho in JAMA. More
It's not the hospitals you might expect... More
We know that consolidation among hospitals and insurance companies leads to higher prices. But what about consolidation in other areas of health care? More
Is the FDA's accelerated approval program resulting in better cancer drugs? Two new studies provide insight... More
The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More